US6316642B1
(en)
*
|
1997-03-17 |
2001-11-13 |
Wisconsin Alumni Research Foundation |
26,27-Homologated-20-EPI-2alkyl-19-nor-vitamin D compounds
|
US5945410A
(en)
*
|
1997-03-17 |
1999-08-31 |
Wisconsin Alumni Research Foundation |
2-alkyl-19-nor-vitamin D compounds
|
US6392071B1
(en)
*
|
1997-03-17 |
2002-05-21 |
Wisconsin Alumni: Research Foundation |
26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
|
MA26481A1
(fr)
*
|
1997-04-21 |
2004-12-20 |
Hoffmann La Roche |
Derives d'arylsecocholadiene
|
US5936105A
(en)
*
|
1997-06-13 |
1999-08-10 |
Tetrionics, Inc. |
14-EPI-19-nor-vitamin D compounds and methods
|
US20030188756A1
(en)
*
|
2002-08-19 |
2003-10-09 |
Cantorna Margherita T |
Treatment of inflammatory bowel disease with vitamin d compounds
|
US6359012B1
(en)
*
|
1999-12-22 |
2002-03-19 |
Bone Care International, Inc. |
Method for making 24(S)-hydroxyvitamin D2
|
ES2309069T3
(es)
*
|
2000-05-31 |
2008-12-16 |
Wisconsin Alumni Research Foundation |
Compuestos de 2-etil y 2-etiliden-19-nor-vitamina d.
|
NZ537036A
(en)
*
|
2000-07-14 |
2006-07-28 |
Wisconsin Alumni Res Found |
Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength
|
BR0113703A
(pt)
*
|
2000-09-08 |
2003-07-22 |
Wisconsin Alumni Researcg Foun |
Compostos e métodos de tratamento de psorìase, leucemia, câncer do cólon, do seio ou da próstata, osteodistrofia renal, de doenças auto-imune, inflamatória e de condição de pele
|
HUP0400210A3
(en)
*
|
2001-03-15 |
2005-11-28 |
Basf Ag |
5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi
|
US6683219B2
(en)
*
|
2001-07-30 |
2004-01-27 |
Wisconsin Alumni Research Foundation |
Synthesis of A-ring synthon of 19-nor-1α,25-dihydroxyvitamin D3 from (D)-glucose
|
US6627622B2
(en)
*
|
2002-02-18 |
2003-09-30 |
Wisconsin Alumni Research Foundation |
(20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
|
ATE411283T1
(de)
*
|
2001-12-13 |
2008-10-15 |
Wisconsin Alumni Res Found |
(20s)-1 alpha-hydroxy-2-methylen-19-nor- bishomopregnacalciferol und ihre verwendungen
|
US6835723B2
(en)
*
|
2001-12-13 |
2004-12-28 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-20(S)-1α-hydroxy-bis-homo-pregnacalciferol in crystalline form
|
US6566352B1
(en)
|
2002-02-18 |
2003-05-20 |
Wisconsin Alumni Research Foudation |
1 α-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
|
US6964784B2
(en)
*
|
2002-03-07 |
2005-11-15 |
Optigenex, Inc. |
Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
|
US20030195175A1
(en)
*
|
2002-03-25 |
2003-10-16 |
Deluca Hector F. |
Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone
|
US6774251B2
(en)
*
|
2002-03-29 |
2004-08-10 |
Wisconsin Alumni Research Foundation |
Method of synthesizing 1α-hydroxy-2-methylene-19-nor-homopregnacalciferol
|
US6846811B2
(en)
*
|
2002-04-22 |
2005-01-25 |
Wisconsin Alumni Research Foundation |
(20S) 1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses
|
US7259143B2
(en)
*
|
2002-09-05 |
2007-08-21 |
Wisconsin Alumni Research Foundation |
Method of extending the dose range of vitamin D compounds
|
US20080249068A1
(en)
*
|
2002-09-05 |
2008-10-09 |
Deluca Hector F |
Method of Extending the Dose Range of Vitamin D Compounds
|
RU2317992C2
(ru)
|
2003-02-25 |
2008-02-27 |
Кей Эн Си Лэборэтериз Ко., Лтд. |
Новые промежуточные соединения для синтеза производных витамина d
|
AU2004230948A1
(en)
*
|
2003-04-10 |
2004-10-28 |
Wisconsin Alumni Research Foundation |
2-propylidene-19-nor-vitamin D compounds
|
US6894037B2
(en)
*
|
2003-07-03 |
2005-05-17 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-20(S)-25-methyl-1α-hydroxycalciferol and its uses
|
CA2531294A1
(en)
*
|
2003-07-03 |
2005-02-10 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-20(s)-25-methyl-1.alpha.-hydroxycalciferol and its uses
|
US20050009792A1
(en)
*
|
2003-07-08 |
2005-01-13 |
Deluca Hector F. |
(20S)-1alpha-hydroxy-2-methylene-19-nor-vitamin D3 and its uses
|
US20050209203A1
(en)
*
|
2003-07-30 |
2005-09-22 |
Jin Tian |
Use of vitamin Ds or vitamin D analogs to treat cardiovascular disease
|
NZ545862A
(en)
*
|
2003-08-20 |
2010-01-29 |
Wisconsin Alumni Res Found |
2-Methylene-19-nor-vitamin D2 compounds
|
WO2005027922A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for the treatment of hypogonadism or andropause
|
WO2005027913A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
|
MXPA06002947A
(es)
*
|
2003-09-19 |
2006-05-31 |
Pfizer Prod Inc |
Derivados de 2-alquilideno-19-nor-vitamina d para el tratamiento de la fragilidad, dano muscular o sarcopenia.
|
WO2005027919A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for the treatment of a second hip fracture
|
WO2005027928A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vit amin d derivatives for the treatment of hypocalcemic tetany or hyproparathyroidism
|
KR20060058135A
(ko)
*
|
2003-09-19 |
2006-05-29 |
화이자 프로덕츠 인코포레이티드 |
골감소증 또는 남성 골다공증의 치료를 위한2-알킬리덴-19-노르-비타민 d 유도체
|
WO2005027927A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for enhancement of peak bone mass in adolescence
|
WO2005027920A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for the treatment of rickets or vitamin d deficiency
|
WO2005027931A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an ep2 or ep4 selective agonist
|
WO2005027925A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for the treatment of anorexia or low bone mass in females exhibiting aggressive athletic behavior
|
WO2005027930A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylene-19-nor-vitamin d derivatives for the treatment of osteosarcoma
|
WO2005027916A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors
|
WO2005027929A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an estrogen
|
WO2005027926A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bone morphogenetic protein
|
WO2005027915A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone
|
EP1667692A1
(en)
*
|
2003-09-19 |
2006-06-14 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an estrogen agonist/antagonist
|
RU2326695C2
(ru)
*
|
2003-09-19 |
2008-06-20 |
Пфайзер Продактс Инк. |
Фармацевтические композиции и способы, включающие комбинации 2-алкилиденовых производных 9-нор-витамина d и бисфосфоната
|
WO2005027918A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a cyclooxgenase-2 inhibitor
|
US7214670B2
(en)
*
|
2003-09-24 |
2007-05-08 |
Wisconsin Alumni Research Foundation |
Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 to increase the life expectancy of human beings
|
US7704980B2
(en)
*
|
2003-10-08 |
2010-04-27 |
Wisconsin Alumni Research Foundation |
Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin D compounds
|
EP1694333A2
(en)
*
|
2003-11-25 |
2006-08-30 |
Deltanoid Pharmaceuticals, Inc. |
Methods for reducing body fat using vitamin d compounds
|
MXPA06005887A
(es)
*
|
2003-11-25 |
2006-06-27 |
Wisconsin Alumni Res Found |
Analogos de vitamina d para la prevencion y el tratamiento de la obesidad.
|
WO2005079464A2
(en)
*
|
2004-02-17 |
2005-09-01 |
Wisconsin Alumni Research Foundation |
Vitamin d receptor antagonists and their use in treating asthma
|
US7214671B2
(en)
*
|
2004-02-19 |
2007-05-08 |
Wisconsin Alumni Research Foundation |
Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 for the prophylaxis of bone diseases
|
US7713951B2
(en)
*
|
2004-04-09 |
2010-05-11 |
Wisconsin Alumni Research Foundation |
2-alkylidene-18,19-dinor-vitamin D compounds
|
US20080293647A1
(en)
|
2004-11-12 |
2008-11-27 |
Luciano Adorini |
Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer
|
EP1838667A2
(en)
*
|
2004-11-22 |
2007-10-03 |
Wisconsin Alumni Research Foundation |
2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses
|
CA2588417C
(en)
*
|
2004-11-22 |
2012-09-18 |
Wisconsin Alumni Research Foundation |
2-methylene-18,19-dinor-1.alpha.-hydroxy-homopregnacalciferol and its uses
|
NZ555562A
(en)
*
|
2004-11-22 |
2009-02-28 |
Wisconsin Alumni Res Found |
2-methylene-19-nor-(20R)-1alpha-hydroxy-bishomopregnacalciferol
|
CA2588060A1
(en)
*
|
2004-11-22 |
2006-06-01 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-(20s)-1alpha-hydroxy-trishomopregnacalciferol
|
US7244719B2
(en)
*
|
2004-11-22 |
2007-07-17 |
Wisconsin Alumni Research Foundation |
2-methylene-19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and its uses
|
ES2358914T3
(es)
*
|
2004-11-22 |
2011-05-16 |
Wisconsin Alumni Research Foundation |
2-metileno-19,21-dinor-1alfa-hidroxi-bishomopregnacalciferol.
|
EP1828114B1
(en)
*
|
2004-11-22 |
2010-04-21 |
Wisconsin Alumni Research Foundation |
17,20(e)-dehydro vitamin d analogs and their uses
|
US7563783B2
(en)
*
|
2005-02-11 |
2009-07-21 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-(20S-24S)-1α,25-dihydroxyvitamin-D2
|
US7511030B2
(en)
*
|
2005-02-11 |
2009-03-31 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-(20S-24epi)-1α,25-dihydroxyvitamin D2
|
WO2006105221A1
(en)
*
|
2005-03-29 |
2006-10-05 |
Wisconsin Alumni Research Foundation |
2-METHYLENE-19-NOR-(23S)-25-DEHYDRO-1α-HYDROXYVITAMIN D3-26,23-LACTONE AND 2-METHYLENE-19-NOR-(23R)-25-DEHYDRO-1α-HYDROXYVITAMIN D3-26,23-LACTONE
|
CA2605727A1
(en)
*
|
2005-05-03 |
2006-11-09 |
Wisconsin Alumni Research Foundation |
19,26,27-trinor-1.alpha.,25-dihydroxyvitamin d3 compounds
|
US7534777B2
(en)
*
|
2005-08-30 |
2009-05-19 |
Wisconsin Alumni Research Foundation |
Des-C,D analogs of 1α,25-dihydroxy-19-norvitamin D3
|
WO2007038094A1
(en)
*
|
2005-09-22 |
2007-04-05 |
Wisconsin Alumni Research Foundation |
19,23,24,25,26,27-hexanor-1alpha-hydroxyvitamin d3
|
US7803789B2
(en)
*
|
2006-02-02 |
2010-09-28 |
Wisconsin Alumni Research Foundation |
Vitamin D analog—RAK, methods and uses thereof
|
US7528122B2
(en)
*
|
2006-02-02 |
2009-05-05 |
Wisconsin Alumni Research Foundation |
Vitamin D analog—NEL, methods and uses thereof
|
WO2007117563A2
(en)
*
|
2006-04-05 |
2007-10-18 |
Wisconsin Alumni Research Foundation |
1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and use thereof
|
US20090281340A1
(en)
*
|
2006-04-05 |
2009-11-12 |
Deluca Hector F |
1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and treatment thereof
|
JP2009533483A
(ja)
*
|
2006-04-06 |
2009-09-17 |
ウイスコンシン アラムニ リサーチ ファンデーション |
2−メチレン−1α,25−ジヒドロキシ−18,19,21−トリノルビタミンD3およびその使用
|
JP2009532457A
(ja)
*
|
2006-04-06 |
2009-09-10 |
ウイスコンシン アラムニ リサーチ ファンデーション |
2−メチレン−1α−ヒドロキシ−18,19,21−トリノルビタミンD3類縁体およびその使用
|
JP2009532459A
(ja)
*
|
2006-04-06 |
2009-09-10 |
ウイスコンシン アラムニ リサーチ ファンデーション |
1,2または3,2複素環を有する19−ノル−ビタミンdアナログ
|
NZ570814A
(en)
*
|
2006-04-06 |
2011-11-25 |
Wisconsin Alumni Res Found |
2-methylene-1alpha-hydroxy-19,21-dinorvitamin D3 analogs and uses thereof
|
WO2008035228A2
(en)
*
|
2006-04-06 |
2008-03-27 |
Wisconsin Alumni Research Foundation |
2- substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin d analogs and uses thereof
|
MX2008012912A
(es)
*
|
2006-04-06 |
2008-11-26 |
Wisconsin Alumni Res Found |
Analogos de 2-metilen-1a,25-dihidroxi-19,21-dinorvitamina d3 y sus usos.
|
US8193169B2
(en)
*
|
2006-04-06 |
2012-06-05 |
Wisconsin Alumni Research Foundation |
(20R)-2α-methyl-19,26,2-trinor-vitamin D analogs
|
DE602007012216D1
(de)
*
|
2006-04-10 |
2011-03-10 |
Wisconsin Alumni Res Found |
1-alpha-hydroxy-2-(3'-hydroxypropyliden)-19-nor-vitamin-d-verbindungen mit einer 1,1-dimethylpropyl-seitenkette
|
MX2009002944A
(es)
*
|
2006-09-28 |
2009-04-02 |
Wisconsin Alumni Res Found |
Analogos de 2-metilen-(20s,25s)-19,27-dinor-(22e)-vitamina d.
|
JP2010504995A
(ja)
*
|
2006-09-28 |
2010-02-18 |
ウイスコンシン アラムニ リサーチ ファンデーション |
2−メチレン−(20r,25s)−19,27−ジノル−(22e)−ビタミンd類縁体
|
US20080171728A1
(en)
*
|
2007-01-12 |
2008-07-17 |
Quatrx Pharmaceuticals Co. |
Efficient Process for Preparing Steroids and Vitamin D Derivatives With the Unnatural Configuration at C20 (20 Alpha-Methyl) from Pregnenolone
|
EP2240440A2
(en)
*
|
2007-12-28 |
2010-10-20 |
Wisconsin Alumni Research Foundation |
2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs
|
WO2009086440A1
(en)
*
|
2007-12-28 |
2009-07-09 |
Wisconsin Alumni Research Foundation |
2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs
|
US8609643B2
(en)
*
|
2007-12-28 |
2013-12-17 |
Wisconsin Alumni Research Foundation |
2-methylene-(20S,25R)-19,26-dinor-vitamin D analogs
|
WO2009086437A1
(en)
*
|
2007-12-28 |
2009-07-09 |
Wisconsin Alumni Research Foundation |
(20r)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs
|
EP2240439B1
(en)
*
|
2007-12-28 |
2015-03-18 |
Wisconsin Alumni Research Foundation |
(20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs
|
AU2009206449B2
(en)
*
|
2008-01-22 |
2014-04-24 |
Wisconsin Alumni Research Foundation |
13,13-Dimethyl-des-C,D analogs of 1alpha, 25-dihydroxy-19-nor-vitamin D3 compounds and topical composition dosage forms and methods of treating skin conditions
|
US8193170B2
(en)
*
|
2008-07-10 |
2012-06-05 |
Wisconsin Alumni Research Foundation |
2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs
|
US7713953B2
(en)
*
|
2008-07-10 |
2010-05-11 |
Wisconsin Alumni Research Foundation |
2-methylene-(22E)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs
|
US7879829B2
(en)
*
|
2008-07-10 |
2011-02-01 |
Wisconsin Alumni Research Foundation |
19-nor-vitamin D analogs with 1,2-dihydrofuran ring
|
US7888339B2
(en)
|
2008-07-10 |
2011-02-15 |
Wisconsin Alumni Research Foundation |
2-methylene-20(21)-dehydro-19-nor-vitamin D analogs
|
US8222236B2
(en)
*
|
2008-07-10 |
2012-07-17 |
Wisconsin Alumni Research Foundation |
2-methylene-(20E)-20(22)-dehydro-19-nor-vitamin D analogs
|
US7893043B2
(en)
|
2008-07-10 |
2011-02-22 |
Wisconsin Alumni Research Foundation |
2-methylene-(17Z)-17(20)-dehydro-19,21-dinor-vitamin D analogs
|
US7648974B1
(en)
*
|
2008-07-10 |
2010-01-19 |
Wisconsin Alumni Research Foundation |
19-nor-vitamin D analogs with 3,2-dihydrofuran ring
|
US8399439B2
(en)
*
|
2008-07-10 |
2013-03-19 |
Wisconsin Alumni Research Foundation |
2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs
|
US20120115824A1
(en)
*
|
2009-04-17 |
2012-05-10 |
Vidasym, Llc |
Vitamin D Receptor Agonists and Uses Thereof
|
JP5908402B2
(ja)
|
2009-08-03 |
2016-04-26 |
ウィスコンシン・アルムニ・リサーチ・ファウンデーションWisconsin Alumni Research Foundation |
腎疾患の予防方法およびその症状を処置する方法
|
WO2011041599A2
(en)
*
|
2009-10-02 |
2011-04-07 |
Wisconsin Alumni Research Foundation |
6-methylvitamin d3 analogs and their uses
|
JP5814247B2
(ja)
*
|
2009-10-02 |
2015-11-17 |
ウィスコンシン・アルムニ・リサーチ・ファウンデーションWisconsin Alumni Research Foundation |
1−デソキシ−2−メチレン−19−ノル−ビタミンd類似体及びそれらの使用
|
US8217023B2
(en)
*
|
2009-10-02 |
2012-07-10 |
Wisconsin Alumni Research Foundation |
19-nor-vitamin D analogs with 1,2- or 3,2-cyclopentene ring
|
US8445468B2
(en)
|
2009-10-02 |
2013-05-21 |
Wisconsin Alumni Research Foundation |
(20S,22E)-2-methylene-19-nor-22-ene-1α,25-dihydroxyvitamin D3
|
AU2010310654B2
(en)
|
2009-10-21 |
2015-05-14 |
Wisconsin Alumni Research Foundation |
Method of preventing Type 1 diabetes
|
US8664206B2
(en)
|
2010-03-23 |
2014-03-04 |
Wisconsin Alumni Research Foundation |
Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3
|
ES2545403T3
(es)
*
|
2010-03-23 |
2015-09-10 |
Wisconsin Alumni Research Foundation |
(20S)-2-metilen-19-nor-22-dimetil-1alfa,25-dihidroxivitamina D3 y (20R)-2-metilen-19-nor-22-dimetil-1alfa,25-hidroxivitamina D3
|
AU2011232562B2
(en)
*
|
2010-03-23 |
2014-10-02 |
Wisconsin Alumni Research Foundation |
Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25- dihydroxyvitamin D3
|
AU2011308911B2
(en)
|
2010-09-30 |
2014-10-02 |
Wisconsin Alumni Research Foundation |
(20R,25S)-2-methylene-19,26-dinor-1alpha, 25-dihydroxyvitamin D3 in crystalline form
|
US8754067B2
(en)
|
2010-11-12 |
2014-06-17 |
Wisconsin Alumni Research Foundation |
22-haloacetoxy-homopregnacalciferol analogs and their uses
|
WO2012151058A1
(en)
|
2011-05-03 |
2012-11-08 |
Wisconsin Alumni Research Foundation |
(20s)-24-(p-toluenesulfonyloxy)-25,26,27-trinorvitamin d3 analogs and their uses
|
WO2012158794A1
(en)
|
2011-05-17 |
2012-11-22 |
Wisconsin Alumni Research Foundation |
N-cyclopropyl-(20r)-2-methylene-19,26,27-trinor-25-aza-vitamin d analogs and their uses
|
CA2837882C
(en)
|
2011-06-03 |
2019-03-26 |
Wisconsin Alumni Research Foundation |
(22e)-2-methylene-26,27-cyclo-22-dehydro-1.alpha.-hydroxy-19-norvitamin d3 derivatives
|
US8993547B2
(en)
|
2011-06-14 |
2015-03-31 |
Wisconsin Alumni Research Foundation |
3-desoxy-2-methylene-19-nor-vitamin D analogs and their uses
|
US10479764B2
(en)
|
2011-06-28 |
2019-11-19 |
Wisconsin Alumni Research Foundation |
2-methylene-(22E)-25-hexanoyl-24-oxo-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs
|
US20130178449A1
(en)
|
2011-07-18 |
2013-07-11 |
Wisconsin Alumni Research Foundation |
2-Methylene-20(21)-Dehydro-19,24,25,26,27-Pentanor-Vitamin D Analogs
|
WO2013032846A1
(en)
|
2011-08-26 |
2013-03-07 |
Wisconsin Alumni Research Foundation |
2-METHYLENE-19,23,24-TRINOR-1α-HYDROXYVITAMIN D3
|
AU2012301422B2
(en)
|
2011-08-30 |
2016-11-10 |
Wisconsin Alumni Research Foundation |
Crystallization of 1 alpha-hydroxy-20-methylene-19,24,25,26,27-pentanorvitamin D3
|
US8420839B1
(en)
|
2011-10-05 |
2013-04-16 |
Wisconsin Alumni Research Foundation |
Crystallization of 1α-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol
|
JP6072811B2
(ja)
*
|
2011-10-21 |
2017-02-01 |
ウイスコンシン アラムニ リサーチ ファンデーション |
2−メチレン−ビタミンd類似体およびそれらの使用
|
JP6114292B2
(ja)
*
|
2011-10-21 |
2017-04-12 |
ウイスコンシン アラムニ リサーチ ファンデーション |
2−メチレン−ビタミンd類似体およびそれらの使用
|
US8729054B2
(en)
|
2011-10-21 |
2014-05-20 |
Wisconsin Alumni Research Foundation |
3-desoxy-2-methylene-vitamin D analogs and their uses
|
US9212137B2
(en)
|
2012-05-30 |
2015-12-15 |
Wisconsin Alumni Research Foundation |
Crystallization of (20R,22R)-2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3 and related precursors
|
US9040728B2
(en)
|
2012-05-30 |
2015-05-26 |
Wisconsin Alumni Research Foundation |
Crystallization of (20R) 19-nor-24-difluoro-1α,25-dihydroxyvitamin D3
|
US8940916B2
(en)
*
|
2012-05-30 |
2015-01-27 |
Wisconsin Alumni Research Foundation |
Crystallization of (20R)-2-methylene-19-nor-24-difluoro-1α,25-dihydroxyvitamin D3
|
US8884039B2
(en)
|
2012-05-30 |
2014-11-11 |
Wisconsin Alumni Research Foundation |
Crystallization of (20R) and (20S) analogs of 2-methylene-19-nor-24-dimethyl-1α,25-dihydroxyvitamin D3
|
US8785422B2
(en)
|
2012-06-06 |
2014-07-22 |
Wisconsin Alumni Research Foundation |
A-ring modified 19-nor-vitamin D analogs and their uses
|
RU2666995C2
(ru)
|
2012-06-29 |
2018-09-13 |
Висконсин Алюмни Рисерч Фаундейшн |
ПРИМЕНЕНИЕ 2-МЕТИЛЕН-19-НОР-(20S)-1α,25-ДИГИДРОКСИВИТАМИНА D3 ДЛЯ ЛЕЧЕНИЯ ВТОРИЧНОГО ГИПЕРПАРАТИРЕОЗА
|
EP2746252A1
(en)
|
2012-12-21 |
2014-06-25 |
Wisconsin Alumni Research Foundation (WARF) |
Crystallization of 1alpha-hydroxy-2-methylene- 18,19-dinor-homopregnacalciferol
|
US9416102B2
(en)
|
2013-01-23 |
2016-08-16 |
Wisconsin Alumni Research Foundation |
(22E)-2-methylene-22-dehydro-1α,24,25-trihydroxy-19-nor-vitamin D3 analogs
|
US10369161B2
(en)
|
2014-12-30 |
2019-08-06 |
Wisconsin Alumni Research Foundation |
Use of 2-methylene-19-NOR-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat primary hyperparathyroidism
|
US9539264B2
(en)
|
2014-12-30 |
2017-01-10 |
Wisconsin Alumni Research Foundation |
Use of 2-methylene-19-nor-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism in patients previously treated with calcimimetics
|
AU2016268399B2
(en)
|
2015-05-26 |
2020-10-15 |
Wisconsin Alumni Research Foundation |
1alpha,25-dihydroxy-24,24-difluoro-19-nor-vitamin D3 analogs and their pharmaceutical uses
|
US20170296558A1
(en)
|
2016-04-18 |
2017-10-19 |
Wisconsin Alumni Research Foundation |
Use of 2amd and 2md to treat fibrosis
|
WO2018044468A1
(en)
|
2016-08-30 |
2018-03-08 |
Wisconsin Alumni Research Foundation |
COMBINATION OF LOW DOSE 2-METHYLENE-19-NOR-(20S)-1α, 25-DIHYDROXYVITAMIN D3 AND CALCIMIMETICS TO TREAT SECONDARY HYPERPARATHYROIDISM
|